For this form of therapy we recommend that rehydration should be done with fluids that do not contain glucose or large amounts of bicarbonate. A loading dose of 05 units of neutral insulin should be given followed by an infusion of neutral insulin at a rate of 40 mU/min (24 U/hr) until the plasma glucose has reached a satisfactory level. Increasing the infusion rate is without additional effect, for the reasons outlined above. The infusion solution consists of 500 ml of physiological saline containing 10 g of human serum albumin and 20 units of neutral insulin. This solution is used over eight hours at 60 ml/hr and is generally suffioient for completion of therapy. Plasma glucose should be measured every second hour when the previous measurement is above 300 mg/100 ml and should be estimated hourly when below this level.
For this form of therapy we recommend that rehydration should be done with fluids that do not contain glucose or large amounts of bicarbonate. A loading dose of 05 units of neutral insulin should be given followed by an infusion of neutral insulin at a rate of 40 mU/min (24 U/hr) until the plasma glucose has reached a satisfactory level. Increasing the infusion rate is without additional effect, for the reasons outlined above. The infusion solution consists of 500 ml of physiological saline containing 10 g of human serum albumin and 20 units of neutral insulin. This solution is used over eight hours at 60 ml/hr and is generally suffioient for completion of therapy. Plasma glucose should be measured every second hour when the previous measurement is above 300 mg/100 ml and should be estimated hourly when below this level.
In addlition to being a simple form of therapy for all degrees of hyperglycaemia and ketoacidosis low dose insulin infusion may offer a more efficient means of preparing diabetics for surgery. Steinke, J., and Thorn, G. W. (1970 (1963) . Lancet, 2, 964. Weisenfeld, S., et al. (1968) . Diabetes, 17, 766. Williams, R. H. (editor) (1968) Medical3Journal, 1974, 2, 694-698 Summary Continuous intravenous infusion of small amounts of insulin has been used in the management of a series ofpatients with diabetic ketoacidosis. In 13 patients with a plasma glucose level on admission of 725 mg/100 ml (+ 80 S.E. of mean) and an arterial pH of 7 07 ± 0 05 a mean loading dose of 6 5 ± 0 82 units of soluble insulin was administered intravenously, and thereafter a sustaining infusion of 6 5 ± 0-82 U/hr was continued until ketosis was corrected and the plasma glucose fell below 300 mg/100 ml. The total insulin dose needed to achieve this was 39 2 + 6 6 units given over a 3 to 10-hour period. (Mohnike et al., 1971) . A regimen of frequent doses of 5-10 U/hr of intramuscular insulin has recently been described by Alberti et al. (1973) , who found it effective in a series of 14 patients. Good results have been reported in three ketoacidotic patients treated with continuous intravenous infusion of human monocomponent insulin in doses as low as 2-7 U/hr (Sonksen et al., 1972) . Insulin is necessary in diabetic ketoacidosis to reverse the disturbed intermediary metabolism and to correct the electrolyte imbalance in conjunction with intravenous fluid therapy. A progessive and predictable return to normal is more likely if insulin is supplied at a regular rate and in quantities which avoid excessive concentration.
The plasma half life of intravenous insulin is only four-five minutes (Turner et al., 1971) so that intravenous boluses need to be repeated often, and they give rise to widely fluctuating plasma insulin levels. Subcutaneous insulin has a half life of about four hours (Binder, 1969) 8, 10, 11, 12, and 13) .
Biochemical details of the patients on admission are shown in table II. In the 13 ketoacidotic patients plasma glucose ranged from 354-1,270 mg/100 ml (mean 725 ± 80) and arterial pH from 6-80-7-36 (mean 7 07 ± 0 05). Pco, ranged from unrecordable to 43 mm Hg and base excess from >-22-0 mmol/l. Admission plasma potassium ranged from 3-5-7-1 mEq/l. (mean 5-3 ± 0 3), plasma sodium from 120-137 mEq/l. (mean 132 1-4), and plasma urea from 26-187 mg/100 ml (mean 89 ± 14.5).
In the ketoacidotic group intravenous fluid therapy was started 15-40 minutes before the administration of insulin, and physiological saline solution (0-154 mol/l.) was used in all cases until plasma glucose had fallen below 300 mg/100 ml, at which time 5% dextrose was substituted. Plasma glucose was measured by a Beckman glucose analyser and plasma potassium by flame photometry. Arterial blood gas estimations were performed using the Astrup method and plasma insulin was measured by a double antibody immunoassay technique (Albano et al., 1972) using human insulin as a standard. Antibodies were obtained from the Wellcome Laboratory, Queensborough, Kent, 1i2aI insulin from the Radio Chemical Centre, Amersham, Buckinghamshire, and insulin standards from the Biological Standards Division, National Institute for Medical Research, Mill Hill, London. The results are given as ± S.E. of mean, and statistical significance was assessed by the t test.
TREATMENT
Fluids.-Saline solution (0154 mol/l.) was used in the initial stages. A mean of 1-76 ± 0-21 litres was given in the first two hours with a mean of 3 3 ± 0 3 in the first six hours. In the first 24 hours a mean of 6-0 4 0-57 litres of intravenous fluid was given to the ketoacidotic patients with a mean positive fluid balance of 3-4 ± 0-8 litres. No intravenous fluid was given to the hyperglycaemic patients (cases 14, 15, and 16).
Potassium.-Intravenous potassium was started on admission only if the plasma potassium was below 5 0 mEq/l. Thereafter potassium was given as soon as the plasma potassium fell below 5 0 mEq/l. In the first four hours of treatment 20 ± 3-2 mEq was given, in the first six hours 42 5 ± 7-5 mEq, and in the first 24 hours 122 ± 13-7 mEq. The doses over the 24-hour period ranged from nil in case 10, a patient who had renal failure, to 210 mEq in the patient in case 1, who was the most severely ketotic patient in the series.
Bicarbonate.-The use of bicarbonate was restricted to four of the patients with an arterial pH of less than 7-0 (cases 1, 3, 4, and 5) and one further patient with a pH of 7-02 who was hypotensive (case 6). Single doses not exceeding 100 mEq were given in 0 5 1. physiological saline (0 154 mol/l.) over 30 minutes together with 20 mEq potassium chloride. The mean dose given to the five patients was 77 ± 11-8 mEq.
Insulin.-Insulin therapy was started in all patients between 15 minutes and 40 minutes after admission to hospital. Twohundred units of soluble insulin were drawn into a 50-ml syringe and diluted up to 50 ml with saline (0-154 mol/l. M) containing 1 g salt-poor human albumin/100 ml (Scottish National Blood Transfusion Association, Edinburgh). Albumin was necessary to reduce adsorption of insulin to the infusion apparatus (Sonksen et al., 1965) . A loading dose of 2-12 units of soluble insulin was given intravenously and a continuous infusion of the insulin solution was then started using a syringe pump (Sage, model 240, Dylade Co. Ltd., Runcorn, Cheshire). The syringe was connected to the patient's intravenous infusion via a manometer connecting tube and a standard Y connector. Insulin was thereafter given at a rate of 2-12 U/hr and the infusion was continued until ketosis was corrected. Ketosis was consideredto be corrected when hyperventilation had ceased, plasma Ketostix gave negative readings, and plasma pH was greater than 7-34, One patient received 2 units as a priming dose and thereafter 2 U/hr (case 8), six patients received 4 units followed by 4 U/hr (cases 2, 7, 10, 11, 12, and 13), four patients received 8 units followed by 8 U/hr (cases 1, 3, 4, and 6), and two patients received 12 units followed by 12 U/hr (cases 5 and 9). The first patients admitted to the study were treated with 12 U/hr to establish the efficacy of the regimen. Subsequent patients were treated with lower doses of insulin, the major factor determining the dose being the severity of the patient's illness. When ketosis was corrected and the plasma glucose fell below 300 mg/100 ml the rate of infusion was either reduced to a maintenance level of between 0-5-2 U/hr for a further 6-12 hours, depending on plasma glucose levels, or subcutaneous insulin was started on a sliding scale determined by urine tests. A mean dose of 39*2 ± 6-6 units was given between the time of admission and control of the ketosis, and the mean time taken to achieve control was 6.4 ± 0 9 hours (range 2-10). The three hyperglycaemic patients received slowly increasing doses of insulin from 0 5 U/hr to 5 U/hr with measurements of plasma insulin at each rate of infusion.
Results
Glucose.-On treatment with insulin and intravenous fluids there was an exponential fall in plasma glucose (see fig.) . The mean BRITISH MEDICAL JOURNAL 29 JUNE 1974 rate of fall of plasma glucose was 101 ± 11 mg/100 ml/hr until intravenous dextrose was begun. In each patient the plasma glucose fell after one hour of therapy and this result was statistically significant by paired t test (P< 0 001). The relatively faster rate of fall in the first hour was probably due to haemodilution. Ketosis.-The response of ketosis to treatment was followed by plasma Ketostix (Ames) measurements at 1, 2, 3, 4, 6, 12, and 24 hours after the beginning of treatment. Negative Ketostix readings with normal ventilation pattern and blood pH were found in all subjects at a mean of 6-4 ± 0-9 hours after the start of insulin therapy (see fig.) . Changes in Plasma Potassium.-Plasma potassium levels were well maintained throughout treatment. In only one patient did the value fall below 3-5 mEq/l. and this was on one occasion at six hours (case 8). Values at 1,2,3, 4, 6, and 12 hours respectively were 4-6 ± 0 35 mEq, 4-4 ± 0-28 mEq, 4.5 ± 0 30 mEq, 4-6 ± 0-32 mnEq, 4.4 ± 0-14 mEq, and 4-6 ± 0-10 mEq/l. during each of the infusion periods and, the results are also shown in table III. An appropriate priming dose was given at the beginning of each infusion period. The observed increments in plasma insulin were proportional to the rate of insulin infusion, and plasma glucose fell in each individual in a linear manner at infusion rates of 1 U/hr and above (mean rate of fall of plasma glucose 115 ± 5 mg/100 ml/hr. Morbidity and Mortality.-Two patients died after correction of ketoacidosis. At necropsy the patient in case 10 had a large cerebral infarct, bronchopneumonia, and thrombus in both atria, and the patient in case 12 had carcinomatosis and bronchopneumonia.
Discussion
Continuous intravenous infusion of small doses of insulin is in our experience effective in the treatment of diabetic ketoacidosis even in the most severe cases (case 1). For many years the standard policy for treatment of this condition has been to give large and frequent doses of insulin (Hudson et al., 1960; Krall, 1963; Cohen et al., 1960; Smith and Martin, 1954; Soler et al., 1973) , and retrospective studies (Soler et al., 1973; Black and Malins, 1949; Root, 1945) have shown that such treatment is effective. The use of large doses of insulin has recently been questioned, and the successful treatment of diabetic ketoacidosis with small frequent subcutaneous and intravenous doses (Mohnike et al., 1971 ) and intramuscular doses (Alberti et al., 1973) has been described. Alberti et al. have found a progressive fall in blood lactate during therapy, in contrast to previously noted observations of a rise during conventional management (Alberti and Hockaday, 1972) , and they have also noted an improvement in the maintenance of plasma potassium levels. It seems to us that the logical method of giving insulin is by continuous intravenous infusion, which produces constant effective plasma levels of insulin, avoids the vagaries of absorption from tissue depots, and overcomes the problem of the short half life of intravenous insulin. Insulin is non-specifically adsorbed to glass and other surfaces (Ferrebee et al., 1951; Hill, 1959; Newerly and Berson, 1957) , and in this study it was given in a 1% solution of human albumin, which is a known competitive inhibitor of insulin adsorption (Sonksen et al., 1965) . Continuous intravenous infusion of large doses of insulin (30-100 U/hr) in the management of diabetic ketoacidosis has previously been reported (Rossier et al., 1960; Gesuth, 1973) . The successful use of a low-dose regimen has been described in the treatment of three ketoacidotic patients by Sonksen et al. (1972) , who infused human monocomponent insulin in a 1% solution of human albumin. The most severely affected patient described responded to a total dose of 34 units of insulin infused over a period of seven hours. The rate of fall of plasma glucose noted in the two series using high doses of insulin was similar to the rate observed in this study, and this may be explained by saturation of the insulin receptors which mediate glucose transport.
Our results show that a priming dose of 2-12 units of soluble insulin intravenously followed by 2-12 units of insulin per hour administered in a 1% solution of human albumin by syringe pump produced a progressive and smooth response of plasma glucose and ketoacidosis to treatment. This regimen has been successful in all cases to date and it has not been necessary to increase the initial rate of insulin infusion. The mean rate of fall of plasma glucose was lower in the patients infused with 2-4 U/hr compared to the patients who received 8-12 U/hr but this difference was not statistically significant. The two groups of patients were not strictly comparable; the low dose group included the patients who had not received insulin before and those with evidence of infection. The mean plasma insulin attained with 4 U/hr was 75-6 ± 8 0 FU/ml, and this is within the range of 20-200 ,U/ml at which insulin has a maximal effect on glucose transport in normal subjects (Sonksen et al., 1972 Greenblatt (1964) showed that side effects were about five times more frequent if a check list was used. The housewife knows, however, that a display of wares in the supermarket is not always desirable; she may select more goods but forget some that she needed. The possibility that the same could be true of side effects prompted this investigation.
Methods
A study of methods of collection of side effects was made as part of a six-month assessment of two analgesic antiinflammatory drugs, aspirin and fenoprofen, the results of which were reported by Huskisson et al. (1974) . Sixty patients with rheumatoid arthritis at two centres received either aspirin or fenoprofen according to a randomized schedule. At one centre patients were simply asked the following question: "Have you noticed any new symptoms which might be related to the treatment ?" At the other centre a check list was also used comprising a list of 21 possible side effects including tinnitus, deafness, and a 
Results
Auditory and gastrointestinal side effects were significantly commoner on aspirin than on fenoprofen. The remainder of the side effects elicited occurred with equal frequency on both drugs and were called "irrelevant." These three groups are shown in table I according to whether or not a check list was used. The group in which no check list was used proved to be more efficient in detecting the two significant groups of side effects. For both auditory and gastrointestinal side effects the incidence on fenoprofen was at least twice as great when a check list was used, and the incidence on aspirin was not correspondingly greater. Thus the difference between the incidence of the significant side effect and the "background" incidence in the control population was diminished. This was particularly apparent for gastrointestinal disturbances, which presumably reflected the frequent occurrence of such symptoms unrelated to treatment.
Irrelevant side effects were much commoner when a check list was used (see table I ). It could be argued that a check list should be used so that the occasional totally unexpected side effect will be reported. That this is not so is shown in table II. While side effects which appeared on the check list (solicited side effects) were much more frequently reported when a check list was used, unsolicited side effects (those which did not appear on the check list) were more likely to be volunteered when a check list was not used. A check list did not much increase the rate of appearance of side effects (see fig.) 
